Who owns Osiris Therapeutics?

Key details on Osiris Therapeutics (Ticker: OSIR)

Who owns Osiris Therapeutics?

Is OSIR a good stock to own? Find out who bought Osiris Therapeutics, who sold Osiris Therapeutics (OSIR) stock, and who holds a large position in Osiris Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 2.24M $36.01M Dec. 31, 2013
BlackRock Fund Advisors 841019 $13.52M Dec. 31, 2013
Vanguard 548087 $8.82M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 515622 $8.29M Dec. 31, 2013
SUSQUEHANNA INTERNATIONAL 406185 $6.53M Dec. 31, 2013
Baker Bros. Advisors 375282 $6.03M Dec. 31, 2013
Dr. Jeffrey R. Jay, M.D 357800 $3.94M June 30, 2012
Inves 323250 $5.38M Sept. 30, 2013
STATE STREET CORPORATION 266681 $2.39M Dec. 31, 2013
LORD, ABBETT & CO 257528 $4.14M Dec. 31, 2013
NORTHERN TRUST 254834 $4.09M Dec. 31, 2013
Roxbury Capital Management 253600 $2.64M March 31, 2013
Hood River Capital Management 252273 $2.54M June 30, 2013
PUTNAM INVESTMENTS 142200 $0 Dec. 31, 2013
Ascend Capital 115000 $1.27M Sept. 30, 2012
Cormorant Asset Management 107800 $1.73M Dec. 31, 2013
GSA Capital Partners 95396 $985440 March 31, 2013
Barclays 91573 $1.46M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 90620 $1.46M Dec. 31, 2013
MORGAN STANLEY 83848 $1.37M Sept. 30, 2013
Bridgeway Capital Management 80200 $886210 Sept. 30, 2012
Geode Capital Management 72669 $1.21M Sept. 30, 2013
TIAA-CREF Investment Management 68268 $1.14M Sept. 30, 2013
ESSEX INVESTMENT MANAGEMENT 68083 $1.09M Dec. 31, 2013
Bank of America Corporation 57509 $958675 Sept. 30, 2013
Eudaimonia Asset Management 54875 $605820 Sept. 30, 2012
Renaissance Technologies 51807 $538792 March 31, 2013
Accipiter Capital Management 50000 $804000 Dec. 31, 2013
UBS AG 46242 $507274 June 30, 2012
BlackRock Investment Management 45753 $736165 Dec. 31, 2013
Jefferies 45663 $734717 Dec. 31, 2013
Credit Suisse AG 43542 $698849 Dec. 31, 2013
Oxford Asset Management 42787 $444984 March 31, 2013
Frank Russell Company 40495 $452329 Sept. 30, 2012
D. E. Shaw & Co 39068 $405916 March 31, 2013
Wellington Management Company 37500 $414000 Sept. 30, 2012
Killen 34600 $556022 Dec. 31, 2013
ALLIANCEBERNSTEIN 34005 $547140 Dec. 31, 2013
CITADEL ADVISORS 33918 $545401 Dec. 31, 2013
Charles Schwab Investment Management 33031 $333943 June 30, 2013

Who sold Osiris Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Jacobs Levy Equity Management Sept. 30, 2011 50154 $256788
WOODSTOCK Sept. 30, 2011 34545 $176870
CalPERS June 30, 2011 35990 $278922
RHUMBLINE ADVISERS March 31, 2010 30549 $226062